Monday, April 4, 2011

Top 20 Generic Companies of The World

WW Unbranded Generic Drug Sales in 2009: Top 20 Companies
WorldWide Generic Sales and GrowthWorldwide Market Share and Growth
Company Name2008       ($b)2009 (\$b)% Growth20082009Change +/-
 Teva Pharmaceutical Industries  7.612.027%15.7%23.6%7.9%
 Novartis  6.86.70-2%13.9%13.1%-0.8%
 Mylan  4.25.0020%8.6%9.9%1.3%
 Actavis  2.32.405%4.8%4.8%0.0%
 Hospira  1.82.1014%3.7%4.1%0.4%
 Watson Pharmaceuticals  1.41.6017%2.9%3.2%0.3%
 STADA Arzneimittel  1.71.60-8%3.5%3.1%-0.4%
 Daiichi Sankyo  0.21.60637%0.4%3.1%2.7%
 Sanofi-Aventis  0.51.40175%1.1%2.8%1.7%
 Apotex  1.31.408%2.6%2.7%0.1%
 Krka  1.31.20-5%2.7%2.4%-0.3%
 Cipla  1.01.1012%2.0%2.1%0.1%
 Par Pharmaceutical  0.51.10136%0.9%2.1%1.2%
 Dr. Reddy's Laboratories  1.11.00-4%2.2%2.1%-0.1%
 Aspen Pharmacare  0.81.0018%1.7%1.9%0.2%
 Fresenius  0.20.90270%0.5%1.7%1.2%
 Sun Pharmaceutical Industries  1.00.90-10%2.0%1.7%-0.3%
 Zydus Cadila  0.60.8022%1.3%1.5%0.2%
 Lupin  0.60.7024%1%1%0.3%
 Total Top 20  37.6044.3018%77%87%0.10
 Other  11.006.40-41%0.230.13-9.9%
 Total  48.6050.804%1.001.00